Global Gabapentin Drug Market Research Report 2020


This report focuses on Gabapentin Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gabapentin Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Pfizer
    Depomed
    Apotex
    Teva
    Acella Pharmaceuticals
    Taro
    Sun Pharmaceutical
    Glenmark
    Amneal Pharmaceuticals
    Aurobindo Pharma
    Zydus Pharmaceuticals
    Hi-Tech Pharmaceuticals
    Marksans Pharma
    Mylan
    InvaGen Pharmaceuticals
    Alkem Laboratories
    Tris Pharma
    ACI HealthCare Limited
    Jiangsu Hengrui Medicine
    CSPC Ouyi Pharmaceutical
    Sciegen Pharmaceuticals
    Epic Pharma
    Lupin Limited

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Capsule
    Tablet
    Oral solution

Segment by Application
    Postherpetic neuralgia in adults
    Partial onset seizures
    Others
Table of Contents

1 Gabapentin Drug Market Overview
    1.1 Product Overview and Scope of Gabapentin Drug
    1.2 Gabapentin Drug Segment by Type
        1.2.1 Global Gabapentin Drug Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 Capsule
        1.2.3 Tablet
        1.2.4 Oral solution
    1.3 Gabapentin Drug Segment by Application
        1.3.1 Gabapentin Drug Sales Comparison by Application: 2020 VS 2026
        1.3.2 Postherpetic neuralgia in adults
        1.3.3 Partial onset seizures
        1.3.4 Others
    1.4 Global Gabapentin Drug Market Size Estimates and Forecasts
        1.4.1 Global Gabapentin Drug Revenue 2015-2026
        1.4.2 Global Gabapentin Drug Sales 2015-2026
        1.4.3 Gabapentin Drug Market Size by Region: 2020 Versus 2026

2 Global Gabapentin Drug Market Competition by Manufacturers
    2.1 Global Gabapentin Drug Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Gabapentin Drug Revenue Share by Manufacturers (2015-2020)
    2.3 Global Gabapentin Drug Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Gabapentin Drug Manufacturing Sites, Area Served, Product Type
    2.5 Gabapentin Drug Market Competitive Situation and Trends
        2.5.1 Gabapentin Drug Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Gabapentin Drug Players (Opinion Leaders)

3 Gabapentin Drug Retrospective Market Scenario by Region
    3.1 Global Gabapentin Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Gabapentin Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Gabapentin Drug Market Facts & Figures by Country
        3.3.1 North America Gabapentin Drug Sales by Country
        3.3.2 North America Gabapentin Drug Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Gabapentin Drug Market Facts & Figures by Country
        3.4.1 Europe Gabapentin Drug Sales by Country
        3.4.2 Europe Gabapentin Drug Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Gabapentin Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Gabapentin Drug Sales by Region
        3.5.2 Asia Pacific Gabapentin Drug Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Gabapentin Drug Market Facts & Figures by Country
        3.6.1 Latin America Gabapentin Drug Sales by Country
        3.6.2 Latin America Gabapentin Drug Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Gabapentin Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Gabapentin Drug Sales by Country
        3.7.2 Middle East and Africa Gabapentin Drug Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Gabapentin Drug Historic Market Analysis by Type
    4.1 Global Gabapentin Drug Sales Market Share by Type (2015-2020)
    4.2 Global Gabapentin Drug Revenue Market Share by Type (2015-2020)
    4.3 Global Gabapentin Drug Price Market Share by Type (2015-2020)
    4.4 Global Gabapentin Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Gabapentin Drug Historic Market Analysis by Application
    5.1 Global Gabapentin Drug Sales Market Share by Application (2015-2020)
    5.2 Global Gabapentin Drug Revenue Market Share by Application (2015-2020)
    5.3 Global Gabapentin Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Gabapentin Drug Business
    6.1 Pfizer
        6.1.1 Corporation Information
        6.1.2 Pfizer Description, Business Overview and Total Revenue
        6.1.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Pfizer Products Offered
        6.1.5 Pfizer Recent Development
    6.2 Depomed
        6.2.1 Depomed Gabapentin Drug Production Sites and Area Served
        6.2.2 Depomed Description, Business Overview and Total Revenue
        6.2.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 Depomed Products Offered
        6.2.5 Depomed Recent Development
    6.3 Apotex
        6.3.1 Apotex Gabapentin Drug Production Sites and Area Served
        6.3.2 Apotex Description, Business Overview and Total Revenue
        6.3.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Apotex Products Offered
        6.3.5 Apotex Recent Development
    6.4 Teva
        6.4.1 Teva Gabapentin Drug Production Sites and Area Served
        6.4.2 Teva Description, Business Overview and Total Revenue
        6.4.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Teva Products Offered
        6.4.5 Teva Recent Development
    6.5 Acella Pharmaceuticals
        6.5.1 Acella Pharmaceuticals Gabapentin Drug Production Sites and Area Served
        6.5.2 Acella Pharmaceuticals Description, Business Overview and Total Revenue
        6.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Acella Pharmaceuticals Products Offered
        6.5.5 Acella Pharmaceuticals Recent Development
    6.6 Taro
        6.6.1 Taro Gabapentin Drug Production Sites and Area Served
        6.6.2 Taro Description, Business Overview and Total Revenue
        6.6.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 Taro Products Offered
        6.6.5 Taro Recent Development
    6.7 Sun Pharmaceutical
        6.6.1 Sun Pharmaceutical Gabapentin Drug Production Sites and Area Served
        6.6.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
        6.6.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Sun Pharmaceutical Products Offered
        6.7.5 Sun Pharmaceutical Recent Development
    6.8 Glenmark
        6.8.1 Glenmark Gabapentin Drug Production Sites and Area Served
        6.8.2 Glenmark Description, Business Overview and Total Revenue
        6.8.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.8.4 Glenmark Products Offered
        6.8.5 Glenmark Recent Development
    6.9 Amneal Pharmaceuticals
        6.9.1 Amneal Pharmaceuticals Gabapentin Drug Production Sites and Area Served
        6.9.2 Amneal Pharmaceuticals Description, Business Overview and Total Revenue
        6.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.9.4 Amneal Pharmaceuticals Products Offered
        6.9.5 Amneal Pharmaceuticals Recent Development
    6.10 Aurobindo Pharma
        6.10.1 Aurobindo Pharma Gabapentin Drug Production Sites and Area Served
        6.10.2 Aurobindo Pharma Description, Business Overview and Total Revenue
        6.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.10.4 Aurobindo Pharma Products Offered
        6.10.5 Aurobindo Pharma Recent Development
    6.11 Zydus Pharmaceuticals
        6.11.1 Zydus Pharmaceuticals Gabapentin Drug Production Sites and Area Served
        6.11.2 Zydus Pharmaceuticals Gabapentin Drug Description, Business Overview and Total Revenue
        6.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.11.4 Zydus Pharmaceuticals Products Offered
        6.11.5 Zydus Pharmaceuticals Recent Development
    6.12 Hi-Tech Pharmaceuticals
        6.12.1 Hi-Tech Pharmaceuticals Gabapentin Drug Production Sites and Area Served
        6.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Description, Business Overview and Total Revenue
        6.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.12.4 Hi-Tech Pharmaceuticals Products Offered
        6.12.5 Hi-Tech Pharmaceuticals Recent Development
    6.13 Marksans Pharma
        6.13.1 Marksans Pharma Gabapentin Drug Production Sites and Area Served
        6.13.2 Marksans Pharma Gabapentin Drug Description, Business Overview and Total Revenue
        6.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.13.4 Marksans Pharma Products Offered
        6.13.5 Marksans Pharma Recent Development
    6.14 Mylan
        6.14.1 Mylan Gabapentin Drug Production Sites and Area Served
        6.14.2 Mylan Gabapentin Drug Description, Business Overview and Total Revenue
        6.14.3 Mylan Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.14.4 Mylan Products Offered
        6.14.5 Mylan Recent Development
    6.15 InvaGen Pharmaceuticals
        6.15.1 InvaGen Pharmaceuticals Gabapentin Drug Production Sites and Area Served
        6.15.2 InvaGen Pharmaceuticals Gabapentin Drug Description, Business Overview and Total Revenue
        6.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.15.4 InvaGen Pharmaceuticals Products Offered
        6.15.5 InvaGen Pharmaceuticals Recent Development
    6.16 Alkem Laboratories
        6.16.1 Alkem Laboratories Gabapentin Drug Production Sites and Area Served
        6.16.2 Alkem Laboratories Gabapentin Drug Description, Business Overview and Total Revenue
        6.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.16.4 Alkem Laboratories Products Offered
        6.16.5 Alkem Laboratories Recent Development
    6.17 Tris Pharma
        6.17.1 Tris Pharma Gabapentin Drug Production Sites and Area Served
        6.17.2 Tris Pharma Gabapentin Drug Description, Business Overview and Total Revenue
        6.17.3 Tris Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.17.4 Tris Pharma Products Offered
        6.17.5 Tris Pharma Recent Development
    6.18 ACI HealthCare Limited
        6.18.1 ACI HealthCare Limited Gabapentin Drug Production Sites and Area Served
        6.18.2 ACI HealthCare Limited Gabapentin Drug Description, Business Overview and Total Revenue
        6.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.18.4 ACI HealthCare Limited Products Offered
        6.18.5 ACI HealthCare Limited Recent Development
    6.19 Jiangsu Hengrui Medicine
        6.19.1 Jiangsu Hengrui Medicine Gabapentin Drug Production Sites and Area Served
        6.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Description, Business Overview and Total Revenue
        6.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.19.4 Jiangsu Hengrui Medicine Products Offered
        6.19.5 Jiangsu Hengrui Medicine Recent Development
    6.20 CSPC Ouyi Pharmaceutical
        6.20.1 CSPC Ouyi Pharmaceutical Gabapentin Drug Production Sites and Area Served
        6.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Description, Business Overview and Total Revenue
        6.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.20.4 CSPC Ouyi Pharmaceutical Products Offered
        6.20.5 CSPC Ouyi Pharmaceutical Recent Development
    6.21 Sciegen Pharmaceuticals
        6.21.1 Sciegen Pharmaceuticals Gabapentin Drug Production Sites and Area Served
        6.21.2 Sciegen Pharmaceuticals Gabapentin Drug Description, Business Overview and Total Revenue
        6.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.21.4 Sciegen Pharmaceuticals Products Offered
        6.21.5 Sciegen Pharmaceuticals Recent Development
    6.22 Epic Pharma
        6.22.1 Epic Pharma Gabapentin Drug Production Sites and Area Served
        6.22.2 Epic Pharma Gabapentin Drug Description, Business Overview and Total Revenue
        6.22.3 Epic Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.22.4 Epic Pharma Products Offered
        6.22.5 Epic Pharma Recent Development
    6.23 Lupin Limited
        6.23.1 Lupin Limited Gabapentin Drug Production Sites and Area Served
        6.23.2 Lupin Limited Gabapentin Drug Description, Business Overview and Total Revenue
        6.23.3 Lupin Limited Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
        6.23.4 Lupin Limited Products Offered
        6.23.5 Lupin Limited Recent Development

7 Gabapentin Drug Manufacturing Cost Analysis
    7.1 Gabapentin Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Gabapentin Drug
    7.4 Gabapentin Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Gabapentin Drug Distributors List
    8.3 Gabapentin Drug Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Gabapentin Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Gabapentin Drug by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Gabapentin Drug by Type (2021-2026)
    10.2 Gabapentin Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Gabapentin Drug by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Gabapentin Drug by Application (2021-2026)
    10.3 Gabapentin Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Gabapentin Drug by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Gabapentin Drug by Region (2021-2026)
    10.4 North America Gabapentin Drug Estimates and Projections (2021-2026)
    10.5 Europe Gabapentin Drug Estimates and Projections (2021-2026)
    10.6 Asia Pacific Gabapentin Drug Estimates and Projections (2021-2026)
    10.7 Latin America Gabapentin Drug Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Gabapentin Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Gabapentin Drug Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Gabapentin Drug Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Gabapentin Drug Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Gabapentin Drug Manufacturers Covered in This Study Table 5. Global Gabapentin Drug Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Gabapentin Drug Sales Share by Manufacturers (2015-2020) Table 7. Global Gabapentin Drug Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Gabapentin Drug Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Gabapentin Drug Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Gabapentin Drug Sales Sites and Area Served Table 11. Manufacturers Gabapentin Drug Product Types Table 12. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Gabapentin Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin Drug as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Gabapentin Drug Players Table 16. Global Gabapentin Drug Sales (K MT) by Region (2015-2020) Table 17. Global Gabapentin Drug Sales Market Share by Region (2015-2020) Table 18. Global Gabapentin Drug Revenue (Million US$) by Region (2015-2020) Table 19. Global Gabapentin Drug Revenue Market Share by Region (2015-2020) Table 20. North America Gabapentin Drug Sales by Country (2015-2020) (K MT) Table 21. North America Gabapentin Drug Sales Market Share by Country (2015-2020) Table 22. North America Gabapentin Drug Revenue by Country (2015-2020) (US$ Million) Table 23. North America Gabapentin Drug Revenue Market Share by Country (2015-2020) Table 24. Europe Gabapentin Drug Sales by Country (2015-2020) (K MT) Table 25. Europe Gabapentin Drug Sales Market Share by Country (2015-2020) Table 26. Europe Gabapentin Drug Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Gabapentin Drug Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Gabapentin Drug Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Gabapentin Drug Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Gabapentin Drug Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Gabapentin Drug Revenue Market Share by Region (2015-2020) Table 32. Latin America Gabapentin Drug Sales by Country (2015-2020) (K MT) Table 33. Latin America Gabapentin Drug Sales Market Share by Country (2015-2020) Table 34. Latin America Gabapentin Drug Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Gabapentin Drug Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Gabapentin Drug Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Gabapentin Drug Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Gabapentin Drug Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Gabapentin Drug Revenue Market Share by Country (2015-2020) Table 40. Global Gabapentin Drug Sales (K MT) by Type (2015-2020) Table 41. Global Gabapentin Drug Sales Share by Type (2015-2020) Table 42. Global Gabapentin Drug Revenue (Million US$) by Type (2015-2020) Table 43. Global Gabapentin Drug Revenue Share by Type (2015-2020) Table 44. Global Gabapentin Drug Price (USD/MT) by Type (2015-2020) Table 45. Global Gabapentin Drug Sales (K MT) by Application (2015-2020) Table 46. Global Gabapentin Drug Sales Market Share by Application (2015-2020) Table 47. Global Gabapentin Drug Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Gabapentin Drug Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. Depomed Gabapentin Drug Corporation Information Table 54. Depomed Corporation Information Table 55. Depomed Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Depomed Main Product Table 57. Depomed Recent Development Table 58. Apotex Gabapentin Drug Corporation Information Table 59. Apotex Corporation Information Table 60. Apotex Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Apotex Main Product Table 62. Apotex Recent Development Table 63. Teva Gabapentin Drug Corporation Information Table 64. Teva Corporation Information Table 65. Teva Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Teva Main Product Table 67. Teva Recent Development Table 68. Acella Pharmaceuticals Gabapentin Drug Corporation Information Table 69. Acella Pharmaceuticals Corporation Information Table 70. Acella Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Acella Pharmaceuticals Main Product Table 72. Acella Pharmaceuticals Recent Development Table 73. Taro Gabapentin Drug Corporation Information Table 74. Taro Corporation Information Table 75. Taro Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Taro Main Product Table 77. Taro Recent Development Table 78. Sun Pharmaceutical Gabapentin Drug Corporation Information Table 79. Sun Pharmaceutical Corporation Information Table 80. Sun Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Sun Pharmaceutical Main Product Table 82. Sun Pharmaceutical Recent Development Table 83. Glenmark Gabapentin Drug Corporation Information Table 84. Glenmark Corporation Information Table 85. Glenmark Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Glenmark Main Product Table 87. Glenmark Recent Development Table 88. Amneal Pharmaceuticals Gabapentin Drug Corporation Information Table 89. Amneal Pharmaceuticals Corporation Information Table 90. Amneal Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Amneal Pharmaceuticals Main Product Table 92. Amneal Pharmaceuticals Recent Development Table 93. Aurobindo Pharma Gabapentin Drug Corporation Information Table 94. Aurobindo Pharma Corporation Information Table 95. Aurobindo Pharma Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Aurobindo Pharma Main Product Table 97. Aurobindo Pharma Recent Development Table 98. Zydus Pharmaceuticals Gabapentin Drug Corporation Information Table 99. Zydus Pharmaceuticals Corporation Information Table 100. Zydus Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. Zydus Pharmaceuticals Main Product Table 102. Zydus Pharmaceuticals Recent Development Table 103. Hi-Tech Pharmaceuticals Gabapentin Drug Corporation Information Table 104. Hi-Tech Pharmaceuticals Corporation Information Table 105. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. Hi-Tech Pharmaceuticals Main Product Table 107. Hi-Tech Pharmaceuticals Recent Development Table 108. Marksans Pharma Gabapentin Drug Corporation Information Table 109. Marksans Pharma Corporation Information Table 110. Marksans Pharma Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. Marksans Pharma Main Product Table 112. Marksans Pharma Recent Development Table 113. Mylan Gabapentin Drug Corporation Information Table 114. Mylan Corporation Information Table 115. Mylan Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 116. Mylan Main Product Table 117. Mylan Recent Development Table 118. InvaGen Pharmaceuticals Gabapentin Drug Corporation Information Table 119. InvaGen Pharmaceuticals Corporation Information Table 120. InvaGen Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 121. InvaGen Pharmaceuticals Main Product Table 122. InvaGen Pharmaceuticals Recent Development Table 123. Alkem Laboratories Gabapentin Drug Corporation Information Table 124. Alkem Laboratories Corporation Information Table 125. Alkem Laboratories Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 126. Alkem Laboratories Main Product Table 127. Alkem Laboratories Recent Development Table 128. Tris Pharma Gabapentin Drug Corporation Information Table 129. Tris Pharma Corporation Information Table 130. Tris Pharma Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 131. Tris Pharma Main Product Table 132. Tris Pharma Recent Development Table 133. ACI HealthCare Limited Gabapentin Drug Corporation Information Table 134. ACI HealthCare Limited Corporation Information Table 135. ACI HealthCare Limited Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 136. ACI HealthCare Limited Main Product Table 137. ACI HealthCare Limited Recent Development Table 138. Jiangsu Hengrui Medicine Gabapentin Drug Corporation Information Table 139. Jiangsu Hengrui Medicine Corporation Information Table 140. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 141. Jiangsu Hengrui Medicine Main Product Table 142. Jiangsu Hengrui Medicine Recent Development Table 143. CSPC Ouyi Pharmaceutical Gabapentin Drug Corporation Information Table 144. CSPC Ouyi Pharmaceutical Corporation Information Table 145. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 146. CSPC Ouyi Pharmaceutical Main Product Table 147. CSPC Ouyi Pharmaceutical Recent Development Table 148. Sciegen Pharmaceuticals Gabapentin Drug Corporation Information Table 149. Sciegen Pharmaceuticals Corporation Information Table 150. Sciegen Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 151. Sciegen Pharmaceuticals Main Product Table 152. Sciegen Pharmaceuticals Recent Development Table 153. Epic Pharma Gabapentin Drug Corporation Information Table 154. Epic Pharma Corporation Information Table 155. Epic Pharma Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 156. Epic Pharma Main Product Table 157. Epic Pharma Recent Development Table 158. Lupin Limited Gabapentin Drug Corporation Information Table 159. Lupin Limited Corporation Information Table 160. Lupin Limited Gabapentin Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 161. Lupin Limited Main Product Table 162. Lupin Limited Recent Development Table 163. Sales Base and Market Concentration Rate of Raw Material Table 164. Key Suppliers of Raw Materials Table 165. Gabapentin Drug Distributors List Table 166. Gabapentin Drug Customers List Table 167. Market Key Trends Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 169. Key Challenges Table 170. Global Gabapentin Drug Sales (K MT) Forecast by Type (2021-2026) Table 171. Global Gabapentin Drug Sales Market Share Forecast by Type (2021-2026) Table 172. Global Gabapentin Drug Revenue (Million US$) Forecast by Type (2021-2026) Table 173. Global Gabapentin Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 174. Global Gabapentin Drug Sales (K MT) Forecast by Application (2021-2026) Table 175. Global Gabapentin Drug Revenue (Million US$) Forecast by Application (2021-2026) Table 176. Global Gabapentin Drug Sales (K MT) Forecast by Region (2021-2026) Table 177. Global Gabapentin Drug Sales Market Share Forecast by Region (2021-2026) Table 178. Global Gabapentin Drug Revenue Forecast by Region (2021-2026) (US$ Million) Table 179. Global Gabapentin Drug Revenue Market Share Forecast by Region (2021-2026) Table 180. Research Programs/Design for This Report Table 181. Key Data Information from Secondary Sources Table 182. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Gabapentin Drug Figure 2. Global Gabapentin Drug Sales Market Share by Type: 2020 VS 2026 Figure 3. Capsule Product Picture Figure 4. Tablet Product Picture Figure 5. Oral solution Product Picture Figure 6. Global Gabapentin Drug Consumption Market Share by Application: 2020 VS 2026 Figure 7. Postherpetic neuralgia in adults Figure 8. Partial onset seizures Figure 9. Others Figure 10. Global Gabapentin Drug Market Size 2015-2026 (US$ Million) Figure 11. Global Gabapentin Drug Sales Capacity (K MT) (2015-2026) Figure 12. Global Gabapentin Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Gabapentin Drug Sales Share by Manufacturers in 2020 Figure 14. Global Gabapentin Drug Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Gabapentin Drug Revenue in 2019 Figure 16. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Gabapentin Drug Sales Market Share by Region (2015-2020) Figure 18. Global Gabapentin Drug Sales Market Share by Region in 2019 Figure 19. Global Gabapentin Drug Revenue Market Share by Region (2015-2020) Figure 20. Global Gabapentin Drug Revenue Market Share by Region in 2019 Figure 21. North America Gabapentin Drug Sales Market Share by Country in 2019 Figure 22. North America Gabapentin Drug Revenue Market Share by Country in 2019 Figure 23. U.S. Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 24. U.S. Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 26. Canada Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Gabapentin Drug Sales Market Share by Country in 2019 Figure 28. Europe Gabapentin Drug Revenue Market Share by Country in 2019 Figure 29. Germany Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 30. Germany Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 32. France Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 34. U.K. Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 36. Italy Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 38. Russia Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Gabapentin Drug Sales Market Share by Region in 2019 Figure 40. Asia Pacific Gabapentin Drug Revenue Market Share by Region in 2019 Figure 41. China Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 42. China Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 44. Japan Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 46. South Korea Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 48. India Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 50. Australia Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 52. Taiwan Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 54. Indonesia Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 56. Thailand Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 58. Malaysia Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 60. Philippines Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 62. Vietnam Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Gabapentin Drug Sales Market Share by Country in 2019 Figure 64. Latin America Gabapentin Drug Revenue Market Share by Country in 2019 Figure 65. Mexico Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 66. Mexico Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 68. Brazil Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 70. Argentina Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Gabapentin Drug Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Gabapentin Drug Revenue Market Share by Country in 2019 Figure 73. Turkey Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 74. Turkey Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 76. Saudi Arabia Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Gabapentin Drug Sales Growth Rate (2015-2020) (K MT) Figure 78. U.A.E Gabapentin Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Gabapentin Drug by Type (2015-2020) Figure 80. Sales Market Share of Gabapentin Drug by Type in 2019 Figure 81. Revenue Share of Gabapentin Drug by Type (2015-2020) Figure 82. Revenue Market Share of Gabapentin Drug by Type in 2019 Figure 83. Global Gabapentin Drug Sales Growth by Type (2015-2020) (K MT) Figure 84. Global Gabapentin Drug Sales Market Share by Application (2015-2020) Figure 85. Global Gabapentin Drug Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Gabapentin Drug by Application (2015-2020) Figure 87. Global Revenue Share of Gabapentin Drug by Application in 2020 Figure 88. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Depomed Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Apotex Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Acella Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Taro Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Zydus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Hi-Tech Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Marksans Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. InvaGen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Alkem Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Tris Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. ACI HealthCare Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. Jiangsu Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. CSPC Ouyi Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 108. Sciegen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. Epic Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 110. Lupin Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 111. Price Trend of Key Raw Materials Figure 112. Manufacturing Cost Structure of Gabapentin Drug Figure 113. Manufacturing Process Analysis of Gabapentin Drug Figure 114. Gabapentin Drug Industrial Chain Analysis Figure 115. Channels of Distribution Figure 116. Distributors Profiles Figure 117. Porter's Five Forces Analysis Figure 118. North America Gabapentin Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 119. North America Gabapentin Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Europe Gabapentin Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 121. Europe Gabapentin Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Latin America Gabapentin Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 123. Latin America Gabapentin Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Middle East and Africa Gabapentin Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 125. Middle East and Africa Gabapentin Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 126. Asia Pacific Gabapentin Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 127. Asia Pacific Gabapentin Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 128. Bottom-up and Top-down Approaches for This Report Figure 129. Data Triangulation Figure 130. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Other Reports by QY Research

Global Cotter Pins Market Research Report 2020

This report focuses on Cotter Pins volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cotter Pins market size by analyzing historical data and future prospect. Regionally, thi...

Global Hacksaws Market Research Report 2020

This report focuses on Hacksaws volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hacksaws market size by analyzing historical data and future prospect. Regionally, this repo...

Global Hex Jam Nuts Market Research Report 2020

This report focuses on Hex Jam Nuts volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hex Jam Nuts market size by analyzing historical data and future prospect. Regionally, t...

Global Power Brush Sweepers Market Research Report 2020

This report focuses on Power Brush Sweepers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Power Brush Sweepers market size by analyzing historical data and future prospec...

Global Spring Snap Market Research Report 2020

This report focuses on Spring Snap volume and value at global level, regional level and company level. From a global perspective, this report represents overall Spring Snap market size by analyzing historical data and future prospect. Regionally, thi...

Publisher: QY Research